ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
76 hedge funds and large institutions have $380M invested in Alpine Immune Sciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 2 closing their positions.
Holders
76
Holders Change
+16
Holders Change %
+26.67%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
34
Reduced
12
Closed
2
Calls
$52K
Puts
–
Net Calls
+$52K
Net Calls Change
+$52K
Top Buyers
1 |
VC
1
Vivo Capital
Palo Alto,
California
|
$9.41M |
2 |
2
BlackRock
New York
|
$23.5M |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$6.95M |
4 |
TLP
4
Tri Locum Partners
New York
|
$3.41M |
5 |
WP
5
Woodline Partners
San Francisco,
California
|
$2.44M |